Blog
RSS FeedPosted by Michael Wonder on 09 May 2022
Choices that fail health and wellbeing
5 May 2022 - NICE's expert group RAPID C-19, set up to ‘to ensure safe and timely patient access to treatments ...
Posted by Michael Wonder on 20 Dec 2021
Biased Outcome reporting Guidelines for Underwhelming Studies (BOGUS) statement and checklist
10 December 2021 - A light hearted article to end the year. Merry Christmas to all our readers. We will ...
Posted by Michael Wonder on 19 Jan 2020
Closing the cycle of innovation in health care in Europe
17 January 2020 - Pragmatic or practice-oriented comparative effectiveness trials may be conducted to fill the evidence gaps that are revealed ...
Posted by Michael Wonder on 20 Sep 2018
Using evidence from randomised controlled trials in economic models: what information is relevant and is there a minimum amount of sample data required to make decisions?
21 September 2018 - Evidence from randomised controlled trials is used to support regulatory approval and reimbursement decisions. ...
Posted by Michael Wonder on 23 Jul 2017
Tackling submission and publication bias
17 July 2017 - Evoniuk and colleagues analysed whether submission and publication bias are based on study outcome. ...
Posted by Michael Wonder on 30 May 2017
NICE to launch new evidence tool for medtech product developers
30 May 2017 - NICE is launching an online tool to help medtech companies get their products to patients faster. ...
Posted by Michael Wonder on 28 Mar 2017
Emerging technology which aims to improve muscle movement is NICE’s 100th medtech innovation briefing
28 March 2017 - NICE’s advice series on new or novel healthcare technology reaches a milestone. ...
Posted by Michael Wonder on 02 Nov 2016
Confounding by indication in clinical research
1 November 2016 - In the assessment of the effect of a treatment or potential risk factor—termed an exposure—on a patient ...